Goldenwell Biotech (GWLL) Other Gross PP&E Adjustments (2021 - 2024)
Goldenwell Biotech's Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$21565.0 for Q1 2024.
- For Q1 2024, Other Gross PP&E Adjustments changed N/A year-over-year to -$21565.0; the TTM value through Mar 2024 reached -$21565.0, changed N/A, while the annual FY2023 figure was -$23665.0, 10.18% up from the prior year.
- Other Gross PP&E Adjustments reached -$21565.0 in Q1 2024 per GWLL's latest filing, up from -$23665.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$21565.0 in Q1 2024 to a low of -$63561.0 in Q1 2021.
- Average Other Gross PP&E Adjustments over 4 years is -$40254.0, with a median of -$38558.5 recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 45.96% in 2022, then rose 10.18% in 2023.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$48752.0 in 2021, then surged by 45.96% to -$26346.0 in 2022, then increased by 10.18% to -$23665.0 in 2023, then grew by 8.87% to -$21565.0 in 2024.
- Per Business Quant, the three most recent readings for GWLL's Other Gross PP&E Adjustments are -$21565.0 (Q1 2024), -$23665.0 (Q4 2023), and -$26346.0 (Q4 2022).